A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)

NCT02356991 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

137

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decides to suspend this trial

Conditions

Non-Small Cell Lung Cancer (NSCLC)

Interventions

DRUG: Famitinib
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.

Collaborators

[object Object]
[object Object]